High Grade B-Cell Lymphoma with Rearrangements of MYC and BCL2 and/or BCL6: Double Hit and Triple Hit Lymphomas and Double Expressing Lymphoma
Conclusions to date have largely been drawn from retrospective data although prospective data is slowly starting to emerge. Chemoimmunotherapy refractoriness is problematic and relapse rates are high.
Source: Blood Reviews - Category: Hematology Authors: Allison Rosenthal, Anas Younes Tags: REVIEW Source Type: research